Skip to main content
. 2024 Jul 7;60(7):1105. doi: 10.3390/medicina60071105

Table 3.

Overview of mortality.

cEVT 1 (N = 47) FS-EVT 2 (N = 24) p-Value
Treatment-associated 30-day mortality [N] (%) 2 (4.3) 1 (4.0) >0.99
30-day mortality total [N] (%) 10 (21.3) 5 (20.8) 0.08
6-month mortality total [N] (%) 1 (2.1) 2 (8.3) 0.26
Completed 12-month follow-up 36 (76.6) 17 (70.8) 0.77

1 cEVT: conventional endoluminal vacuum therapy; 2 FS-EVT: fistula sponge–endoluminal vacuum therapy.